Ligand validation:8B1D

D12: DODECANE

D12 is a Ligand Of Interest in 8B1D designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8B1D_D12_A_809	0%	71%	0.6	0.542	0.39	0.71	-	-	0	0	100%	1
8B1I_D12_A_809	7%	72%	0.309	0.757	0.5	0.57	-	-	0	0	100%	1
8B18_D12_A_809	5%	73%	0.34	0.738	0.42	0.63	-	-	0	0	100%	1
8B1A_D12_A_809	3%	70%	0.284	0.618	0.37	0.77	-	-	0	0	100%	1
8B1E_D12_A_809	1%	71%	0.45	0.585	0.43	0.68	-	-	0	0	100%	1
8B17_D12_A_809	0%	71%	0.684	0.68	0.42	0.7	-	-	0	0	100%	1
3UTY_D12_A_501	99%	67%	0.058	0.988	0.22	1.03	-	1	0	0	100%	1
3UTX_D12_B_401	94%	12%	0.076	0.977	1.73	2.32	2	5	0	0	100%	1
6W84_D12_A_404	75%	70%	0.118	0.951	0.29	0.85	-	-	0	0	100%	1
9QWJ_D12_B_908	72%	90%	0.112	0.934	0.27	0.33	-	-	0	0	100%	1
4Y9H_D12_A_305	70%	83%	0.094	0.909	0.26	0.52	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.